Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Nasdaq Biotechnology Ishares ETF
(NQ:
IBB
)
148.17
-0.11 (-0.07%)
Official Closing Price
Updated: 4:15 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Nasdaq Biotechnology Ishares ETF
< Previous
1
2
3
4
5
6
7
8
9
...
24
25
Next >
3 Under-the-Radar Biotech Stocks With Upcoming Catalysts in 2024
February 26, 2024
Find out which under-the-radar biotech stocks have major catalysts on the horizon, and unlock their explosive growth potential.
Via
InvestorPlace
Lottery Preference And Biotech Stocks: Trust The Financials, Not The Science
February 25, 2024
Making a bet on biotech/pharma firms that have not yet achieved significant revenue is the equivalent of buying a lottery ticket—with the same poor risk/return relationship.
Via
Talk Markets
Healthcare Stocks Are Looking Better But What About Biotech?
February 20, 2024
Large cap biopharmacuiticals remain a core holding for growth and value despite political cross-currents on drug pricing.
Via
Talk Markets
Has The Solar ETF TAN Bottomed?
February 07, 2024
The last swing high before the huge parabolic move in TAN in 2020 was exactly where the current price was.
Via
Talk Markets
Topics
ETFs
The Transportation Sector Has A Story To Tell
February 05, 2024
With the market experiencing a dose of reality on interest rates, we still believe that current rates are not the worst news for the market, depending on where you look.
Via
Talk Markets
Healthcare And Life Science Funds And ETFs Performance 2023-2024
February 05, 2024
Healthcare stocks usually provide a defensive posture to a stock portfolio.
Via
Talk Markets
Topics
ETFs
AI, Biotech, Energy Sectors Expect M&A Revival For 2024
January 29, 2024
The AI market, along with energy and biotech, are ripe for M&A following the worst performance in almost a decade for deal-making in 2023.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Top Thematic ETF Ideas For 2024
January 24, 2024
With AI adoption and spending expected to expand this year, new avenues for business growth will open up for tech companies beyond the Magnificent Seven.
Via
Talk Markets
Topics
Artificial Intelligence
ETFs
Exposures
Artificial Intelligence
Bullish Continuation In '24? 3 Market Areas To Watch
January 10, 2024
This article discusses 3 market areas that should outperform dramatically over the next 12 months...
Via
Talk Markets
Markets: Week 1 Week 2 - What's Next Week 3?
January 10, 2024
The growth space is getting crowded again, while the
Via
Talk Markets
A Rough Start To 2024 What Might Be In Store For The Rest Of 2024?
January 07, 2024
The market was weighed down by several negative factors that began before the bell even rang at Broad and Wall on the first trading day of this New Year.
Via
Talk Markets
Will the Biotech sector sustain its momentum in 2024?
January 04, 2024
The iShares Biotechnology ETF (NASDAQ: IBB) emerged as a standout star, closing the first day of the year with a solid upswing of nearly 4%.
Via
MarketBeat
Topics
ETFs
US Stocks Eye 3-Day Slump; Tech, Crypto Sell-Off Deepens, Oil, Dollar Rebound: What's Driving Markets Wednesday?
January 03, 2024
The early 2024 sell-off is intensifying on Wall Street, with all major stock averages in the red on the second trading day of 2024.
Via
Benzinga
Tech Drags On Wall Street As 2024 Kicks Off; Dollar and Treasury Yields Surge: What's Driving Markets Tuesday?
January 02, 2024
Wall Street kicked off 2024 on a weaker note, with the S&P 500 dipping by 0.5%, and the Nasdaq 100 experiencing a 1.4% decline in midday trading in New York.
Via
Benzinga
Top Biotech Picks For 2024: Piper Sandler Foresees Potential Sector Comeback
December 29, 2023
Piper Sandler sees potential turnaround for Biotech sector in 2024, identifies thee top stocks; Arrowhead, Legend Biotech & Alnylam Pharmaceuticals.
Via
Benzinga
Wall Street Sees Post-Holiday Gains, Oil Rallies, Intel Leads: What's Driving Markets Tuesday?
December 26, 2023
The U.S. stock market saw modest gains in a session characterized by low trading volumes following the Christmas holiday. The S&P 500 Index gained 0.3% during midday trading in New York, eyeing its...
Via
Benzinga
S&P 500, Nasdaq 100 Aim For 8th Week Of Gains As Fed's Inflation Gauge Cools: What's Driving Markets Friday?
December 22, 2023
The S&P 500 and Nasdaq 100 indices are on the verge of achieving an impressive eight consecutive weeks of gains following a more significant decline than expected in the Federal Reserve’s favored...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
US Stocks Bounce; Chipmakers, Cruise Lines Lead, Dollar Falls: What's Driving Markets Thursday?
December 21, 2023
On Thursday, Wall Street rebounded into positive territory, following a brief dip experienced on Wednesday. At midday trading New York time, all major stock indices were trading in the green as traders...
Via
Benzinga
Wall Street Edges Higher, Small Caps Eye Best Month In 3 Years, Bitcoin Rebounds: What's Driving Markets Wednesday?
December 20, 2023
Stocks inched higher during midday trading in New York on Wednesday, with the momentum carrying over from the previous day when the tech-heavy Nasdaq 100 achieved fresh record highs.
Via
Benzinga
Biotech Is Coming Back, Can The Run Last?
December 11, 2023
The rally can be attributed to lower interest rates and seasonal factors from the end of Q4 through January. But recently some major biopharmaceutical deals have supported the rally.
Via
Talk Markets
MarketBeat Week in Review – 12/4 - 12/8
December 09, 2023
Stocks finished in the green to close the week; investors believe the jobs report will allow the Fed to leave interest rates unchanged when they meet next week
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
3 biotech powerhouses poised to thrive amid sector rebound
December 08, 2023
If the newfound support and uptrend in the biotech sector last, as the new year quickly approaches, the biotech sector could shift from lagger to leader.
Via
MarketBeat
Topics
ETFs
Biotech reversal confirmed: what's ahead for the IBB?
December 08, 2023
The recent reversal and reclaim of the significant $124 support level in the IBB holds importance, indicating a potential shift in momentum.
Via
MarketBeat
Topics
ETFs
Biotech And Healthcare Portfolio Playbook For December 2023/24
November 27, 2023
We are having a great but choppy market recovery over the past four weeks and it looks like it should continue through to the next earnings cycle in January.
Via
Talk Markets
Are You A Trader Or Investor: Biotech Momentum Is Picking Up
November 20, 2023
ETFs have not helped as portfolio fillers but they can identify trends. We should play this rally out of a biotech bear market.
Via
Talk Markets
Topics
ETFs
You Don't Have to Pick a Winner in Biotech. Here's Why.
November 18, 2023
If you invest over the long term, you'll increase your chances of victory.
Via
The Motley Fool
Under the Microscope: 3 Biotech Stocks Pioneering Tomorrow’s Cures
November 09, 2023
Unveil the resilience of biotech stocks as they outsmart market trends and champion the race for tomorrow's treatments.
Via
InvestorPlace
Healthcare Playbook: Hardly Defensive With A Covid Hangover In Biotech
November 01, 2023
Market Bubbles may take a long time to clear and we created a big one in July 2021 dealing with the COVID pandemic.
Via
Talk Markets
Exposures
COVID-19
Pivotal Week Coming Up: Big Tech Earnings, Geopolitics, Technicals, Treasury Yield...
October 23, 2023
The upcoming quarter GDP is expected to hit 3.7% which has brought the FED dialogue to “higher rates for longer” which might lead us to a recession in 2024. So watch the yield on the 10-year TSY now at...
Via
Talk Markets
Topics
Economy
Exposures
Economy
When News Moves So Fast, Stocks Can Stand Still
October 16, 2023
As far as the market goes, it feels like time is standing still.
Via
Talk Markets
< Previous
1
2
3
4
5
6
7
8
9
...
24
25
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.